Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Investing Activities

    Back to Cashflow Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Investing Activities ₹-1,283 Cr₹2.09 Cr₹4,561 Cr₹-528 Cr₹-333 Cr

What is the latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS is ₹-1,283 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Investing Activities
Mar2026₹-1,283 Cr
Mar2025₹2.09 Cr
Mar2024₹4,561 Cr
Mar2023₹-528 Cr
Mar2022₹-333 Cr

How is Cash Flow from Investing Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Investing Activities % Change
Mar2026 ₹-1,283 Cr
Negative
Mar2025 ₹2.09 Cr
-99.95
Mar2024 ₹4,561 Cr
Positive
Mar2023 ₹-528 Cr
Negative
Mar2022 ₹-333 Cr -

Compare Cash Flow from Investing Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹67,389.4 Cr 5.3% 3.4% 27.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,202.0 Cr 0.5% -2.9% 5% Stock Analytics
DIVIS LABORATORIES ₹264,141.0 Cr 5% 7.2% 49.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,402.0 Cr -0.5% -4.5% 28.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,868.0 Cr 2.7% 8.4% 5.1% Stock Analytics
CIPLA ₹111,650.0 Cr 2.4% 2.4% -12.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

5.3%

3.4%

27.4%

SENSEX

2.8%

4.4%

-10.1%


You may also like the below Video Courses